Evidence Synthesis, Modeling & Communication

Transforming Evidence into Value

Our Evidence Synthesis, Modeling & Communication team understands the challenges associated with creating the full and persuasive evidence package you need to differentiate your product in the marketplace and satisfy the requirements of multiple stakeholders. Our experts work to address your specific needs and can bring together the right pieces of evidence across the HEOR and market access spectrum that resonate with payers and health technology assessments (HTAs).

Connect With Us

A Holistic Approach to Demonstrate the Value of your Asset

Our multi-disciplinary team of scientific, clinical, and strategic experts provide a holistic and flexible approach to HEOR and market access studies to adapt to your needs. We leverage our diverse set of industry-leading experts across evidence synthesis, modeling and simulation, and market access communications to provide end-to-end support and guidance across projects throughout the lifecycle of an asset. This approach allows us to address the whole picture of the asset’s characteristics, from providing early actionable information to help make development decisions, to guidance on product launch activities that work best with your goals. Our dedicated project managers serve as a single point-of-contact to track large bodies of work resulting in efficient, on-time programs.

Learn how we provide tailored evidence generation solutions for the unique needs of large and mid-size pharmaceutical companies, biotech companies, vaccine manufacturers, and device companies

Click to read Transforming Evidence into Value

Positioning Your Asset for Global Success

We understand the need to develop strategies to expand your product’s reach across a range of geographies. Our HEOR experts span the globe and can help translate your country-level launch strategy and push further to position your product for global success. With more than 180 scientists, statisticians, modelers, and consultants across Europe, North America, and Asia, our team has substantial knowledge of country-specific requirements that can be applied across project types.

Our Experience

15+ therapeutic areas

200+ indications worked across

130+ HTA submissions

supported in the past five years

180+ global HEOR experts

including statisticians, modelers and consultants

300+ systematic literature reviews

completed in the past five years

130+ peer-reviewed publications per year

125+ NMAs completed in the past five years

Leveraging Relationships to Navigate Payer Challenges

With long-standing and deep relationships across the HTA and market access ecosystem, our experts are well-positioned to help you navigate payer challenges. Our network includes multiple agencies and organizations including HTAs, payers, providers, and academia. Several of our team members have held or are currently holding roles across industry groups including ISPOR. Additionally, our teams have created some of the industry’s most cutting-edge technologies to address market access hurdles and have helped shape industry trends.

Our Specialty Areas

Evidence Synthesis

Unlock the value of published and "grey" literature to build your foundation of evidence

Network Meta-Analysis
Literature Reviews
Evidence Surveillance
Evidence Mapping
Rapid Literature Reviews
Simulated Treatment Comparisons (STC) and Matching-Adjusted Indirect Comparisons (MAIC)

Learn More